# Your page scores 17 out of 100 for sameness against the competitor you named — low enough that buyers can probably tell you apart.

You are telling a different story from Medscout and the rest of the set, overlapping only on how the page looks.

- **Your page:** https://www.acuitymd.com/
- **Compared against:** Medscout (medscout.com)
- **Sameness Index:** 17 — Mostly your own
- **Ownable share:** 26% (of 100% distinctive)
- **Report:** https://grader.wynter.com/c/acuitymd-com-KI_eDcU

**How you compare · vs 366 SaaS sites** — 39 points less same than the average SaaS site. The average SaaS site scores 56; you scored 17. You are less same than 362 of the 366 SaaS sites. The best-differentiated site in the set is at 6.
_A single check can move several points between runs; the benchmark averages up to eight sites per category._

> With 1 competitor, commonness can only take 2 distinct values. The figures are honest at that resolution and no finer.

## 1. Sameness Index

| Category | Weight | Score | What it means |
| --- | --- | --- | --- |
| Messaging | 30% | 22 | The most expensive kind of sameness. A buyer cannot tell what job you do that the others do not. |
| Claims | 30% | 0 | Every shared claim is a line already read on another tab. Cut the ones nobody owns and spend the space on something they cannot. |
| Features | 15% | 18 | Expected in a mature category, and the least alarming of the six. Feature parity is normal; leading with it is the mistake. |
| Proof | 10% | 13 | Same kinds of proof as everyone means the proof stops working as proof. It is scored on the kind of evidence, not on which customers are named. |
| Structure | 10% | 34 | The generic SaaS template — hero, logos, three-feature grid, testimonial, CTA. Familiar is not the same as memorable. |
| Visual | 5% | 60 | Weighted lowest on purpose: buyers rarely decide on this. Worth knowing, rarely worth fixing first. |

**Mostly your own** — Most of what you say, your competitors don't.

## 2. Closest competitors

| Competitor | Echoes your claims |
| --- | --- |
| Medscout | 17% |

_Measured from your side: the share of what YOU say that each competitor also says, weighted by where you put it. This is not a Sameness Index — a competitor can echo most of your page and still score low on its own index by saying a great deal you do not._

## 3. Ownable share

**The share of your own page's claim space that is yours to keep.** This is not the inverse of the Sameness Index — it is measured on your claims alone, so the two do not add up to 100 and are not meant to.

26% of your page is unique, relevant and defensible — a strong share, and the thing to protect in any rewrite.

- **Distinctive message share:** 100% — prominent space spent on claims no competitor makes.
- **Ownable share:** 26% — the part of that which is also relevant to how buyers choose and hard to copy.

## 4. Where you sound like everyone else

Most of your set makes each of these and you are spending prominent space on them, ranked by how much. **These are not necessarily lines to delete** — some of what a page has to say is unavoidably shared, and claims about what kind of product you are were left out of this list for exactly that reason. The question each one raises is whether it has earned its space.

- **customer testimonial** (Section, 100% of the set) — also on Medscout
  - _"I wish I had this when I was a rep"_
  - Said your way: nobody else makes this exact claim, but everyone occupies the territory.
- **purpose-built for the industry vertical** (Section, 100% of the set) — also on Medscout
  - _"AcuityMD helps your team execute with confidence whether launching innovations, expanding territories, or building physician relationships"_
  - Said your way: nobody else makes this exact claim, but everyone occupies the territory.

## 5. Buried gold

Unique, relevant, and sitting in body copy. The cheapest wins here — you already have the differentiation and the page hides it.

- **Achieved 97% forecast accuracy** (Body, 0% of the set)
  - _"97% forecast accuracy (Route 92 Medical)"_
- **Customers report large revenue increases after adopting** (Body, 0% of the set)
  - _"We've increased revenue dramatically every year since launching in the U.S. (Kuros Biosciences)"_
- **Data replaces gut feel with defensible decisions** (Body, 0% of the set)
  - _"AcuityMD gives us the grounding in data we need to justify every decision and the confidence to expand intelligently (Kuros Biosciences)"_
- **Faster new-rep onboarding** (Body, 0% of the set)
  - _"10x faster onboarding (Route 92 Medical)"_
- **High rep adoption and daily usage rates** (Body, 0% of the set)
  - _"93% monthly active users (Aerin Medical)"_
- **Named customer reach and pipeline result metrics** (Body, 0% of the set)
  - _"3,500+ providers and sites of care reached (Aerin Medical)"_
- **Physician-level payer mix and procedure volume data** (Body, 0% of the set)
  - _"Seeing payer mix and procedure volume at the physician level ensures reps don't spend time on accounts that aren't a fit"_
- **Quoting removes bottlenecks, gives reps account ownership** (Body, 0% of the set)
  - _"AcuityMD Quoting has removed bottlenecks and given salespeople ownership over accounts (AnX Robotica)"_
- **Reps see daily performance and next actions** (Body, 0% of the set)
  - _"Reps log in each morning and see exactly where they're up or down month-to-date and what to act on (Corza Biosurgery)"_
- **Saves reps significant administrative hours monthly** (Body, 0% of the set)
  - _"25+ hours per month saved (AnX Robotica)"_
- **Shortens time from outreach to close** (Body, 0% of the set)
  - _"Faster sales process, fewer weeks from initial outreach to close"_

## 6. Claim inventory

| Claim | Type | Placement | Common | Sayability | Relevant | Ownership |
| --- | --- | --- | --- | --- | --- | --- |
| Purpose-built platform for MedTech commercial teams | category | Hero | 0% | some | yes | Unique and owned |
| AI capability built into the platform | capability | Hero | 0% | anyone | yes | Unique for now |
| AI users are 3x more likely to hit quota | proof | Hero | 0% | some | yes | Unique and owned |
| Move faster on best opportunities with aligned teams | outcome | Hero | 0% | anyone | yes | Unique for now |
| Trusted by 500+ medical device companies | proof | Hero | 0% | some | yes | Unique and owned |
| Reps wish they had had this tool | proof | Section | 0% | anyone | no | Unique for now |
| Supports launches, expansion and physician relationships | capability | Section | 0% | anyone | yes | Unique for now |
| Aligns marketing campaigns with sales opportunity | capability | Section | 0% | anyone | no | Unique for now |
| Better pipeline visibility and forecast accuracy for leaders | outcome | Section | 0% | anyone | yes | Unique for now |
| Drives faster revenue growth and product adoption | outcome | Section | 0% | anyone | yes | Unique for now |
| Industry-leading data delivered in usable format | quality | Section | 0% | anyone | yes | Unique for now |
| Prioritizes high-value accounts with insights in one place | outcome | Section | 0% | anyone | yes | Unique for now |
| Reps spend more time selling, less searching | outcome | Section | 0% | anyone | yes | Unique for now |
| Surfaces whitespace and under-penetrated accounts to target | capability | Section | 0% | anyone | yes | Unique for now |
| Territory mapping and growth planning on market data | capability | Section | 0% | anyone | yes | Unique for now |
| Achieved 97% forecast accuracy | proof | Body | 0% | anyone | yes | Unique for now |
| Customers report large revenue increases after adopting | proof | Body | 0% | anyone | yes | Unique for now |
| Data replaces gut feel with defensible decisions | proof | Body | 0% | anyone | yes | Unique for now |
| Faster new-rep onboarding | proof | Body | 0% | anyone | yes | Unique for now |
| High rep adoption and daily usage rates | proof | Body | 0% | anyone | yes | Unique for now |
| Named customer reach and pipeline result metrics | proof | Body | 0% | anyone | yes | Unique for now |
| Physician-level payer mix and procedure volume data | proof | Body | 0% | some | yes | Unique and owned |
| Quoting removes bottlenecks, gives reps account ownership | proof | Body | 0% | some | yes | Unique and owned |
| Reps see daily performance and next actions | proof | Body | 0% | anyone | yes | Unique for now |
| Saves reps significant administrative hours monthly | proof | Body | 0% | anyone | yes | Unique for now |
| Shortens time from outreach to close | outcome | Body | 0% | anyone | yes | Unique for now |

## What we compared

- **AcuityMD** (your page) — https://www.acuitymd.com/
- **Medscout** — https://www.medscout.com/en

## What this does and does not tell you

An AI read each page and wrote down the claims it makes, then grouped the claims that say the same thing. **No score in this report was written by a model** — every number is computed from those groupings in our own code, with the weights shown above.

## The only way to know if it matters

This report can tell you where your messaging overlaps. It cannot tell you whether a buyer would care, or which of your reasons to buy actually land. Put the page in front of real B2B buyers in your target market and ask them.

[Test it with real buyers](https://wynter.com)